Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
COPENHAGEN, Denmark, November 23, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been...
News
Resolutions of the Extraordinary General Meeting of BioPorto A/S
November 23, 2022 Announcement no. 17 Resolutions of the Extraordinary General Meeting of BioPorto A/S COPENHAGEN, DENMARK and BOSTON, MA,...
Notice of AGM
DXS INTERNATIONAL PLC Notice of 2022 Annual General Meeting The Board of DXS International plc (the “Company”), the AQSE Growth...
PCI Biotech interim Q3 2022 report
Oslo (Norway), 23 November 2022 – PCI Biotech (OSE: PCIB), today announces its interim Q3 2022 results. Please find enclosed...
CinCor Pharma to Present at Upcoming Piper Sandler and Evercore ISI Investor Conferences
WALTHAM, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that company management will present...
Children Treated With Remestemcel-L Show Long-Term Survival Through Four Years in Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)
Key Points: Long-term survival evident through 4 years in children treated with remestemcel-L in Phase 3 trial MSB-GVHD001Overall survival at...
Mesoblast Reports Financial Results and Operational Highlights for the Period Ended September 30, 2022
Durable long-term survival outcomes through 4 years for children with steroid-refractory graft versus host disease (SR-aGVHD) treated with remestemcel-L These...
Amedisys Names Scott Ginn Acting Chief Operating Officer
BATON ROUGE, La., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal...
Supernus to Present at the Piper Sandler 34th Annual Healthcare Conference
ROCKVILLE, Md., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
uniQure announces FDA approval of first gene therapy for adults with hemophilia B
Lexington Facility uniQure's commercial manufacturing facility in Lexington, MA Manufacturing State-of-the-art global commercial manufacturing at uniQure~ Historic approval provides a...
Jushi Holdings Inc. Files a Copy of its S-1 Registration Statement in Canada
BOCA RATON, Fla., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF),...
West Coast Academic Medical Center Signs New Contract for Streamline Health® eValuator™
Chooses Automated Pre-Bill Coding Analysis to Improve Financial Performance Atlanta, GA, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Streamline Health Solutions,...
DBV Technologies to Participate in Upcoming Investor Conference
Montrouge, France, November 22, 2022 DBV Technologies to Participate in Upcoming Investor Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345...
First Wave BioPharma, Inc. Announces Closing of Private Placement
BOCA RATON, Fla., Nov. 22, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”),...
Hyperfine to Present at the 5th Annual Evercore ISI HealthCONx Conference
GUILFORD, Conn., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop®, the...
ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
- Acquisition expands ResMed’s SaaS business to Germany, first non-U.S. market - Outpatient therapy services added to ResMed’s growing SaaS offering...
CNS Summit Releases Annual CNS Summit Innovation Index
BOCA RATON, Fla., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Released at the CNS Summit in Boca Raton, FL, the CNS...
Qualigen Therapeutics, Inc. Announces 1-for-10 Reverse Stock Split
Action to comply with continued listing requirements for Nasdaq Capital Market CARLSBAD, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Qualigen...
BioCorRx Board of Directors Approves Exploration of Potential Spin-Off of BioCorRx Pharmaceuticals, Inc.
ANAHEIM, CA, Nov. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and...
Rio Tinto donates $500,000 to the MUHC Foundation to fight antimicrobial resistance
The gift will create the Antimicrobial Resistance Discovery Incubator, which will fund innovative new projects to prevent and treat drug...